Efficacy and safety of pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV): results of a phase 2 study after a 7-year median follow-up

BACKGROUND: The durability of responses and long-term safety of pegylated interferon alpha-2a (PEG-IFN-a-2a) in patients with polycythemia vera and essential thrombocythemia have not been reported. Here, we present long-term efficacy and safety data from a single-center, prospective, phase 2 study,...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Lancet Haematol
Главные авторы: Masarova, Lucia, Patel, Keyur P., Newberry, Kate J., Cortes, Jorge, Borthakur, Gautam, Konopleva, Marina, Estrov, Zeev, Kantarjian, Hagop, Verstovsek, Srdan
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421384/
https://ncbi.nlm.nih.gov/pubmed/28291640
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(17)30030-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы